Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 12
2003 15
2004 20
2005 24
2006 19
2007 15
2008 22
2009 32
2010 30
2011 39
2012 48
2013 38
2014 33
2015 53
2016 42
2017 39
2018 51
2019 53
2020 84
2021 97
2022 114
2023 80
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

877 results

Results by year

Filters applied: . Clear all
Page 1
Shanghai Gynecologic Oncology Group's Consensus on the academic and industry's clinical trial types.
Shi T, Liu J, Zhu J, Wang X, Jiang W, Lu X, Feng W, Zhou S, Shen Y, Chen G, Wu Z, Zou D, Wu P, Yang H, Wu S, Zhu T, Wang H, Zhang Y, Qiu L, Guo X, Xiang L, Zhang W, Ren Y, Feng Y, Liu Y, Chen X, Zang R; Shanghai Gynecologic Oncology Group (SGOG). Shi T, et al. Among authors: liu j. Chin Med J (Engl). 2024 Apr 24. doi: 10.1097/CM9.0000000000003146. Online ahead of print. Chin Med J (Engl). 2024. PMID: 38654409 No abstract available.
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).
Kobayashi Y, Shimada M, Tamate M, Cho HW, Zhu J, Chou HH, Kajiyama H, Okamoto A, Aoki D, Kang S, Lee JW, Kim JW, Kim JH, Lin Z, Liu J, Wu X, Lai HC, Chang TC, Lai CH, Kim YM, Enomoto T. Kobayashi Y, et al. Among authors: liu j. J Gynecol Oncol. 2024 Apr 3. doi: 10.3802/jgo.2024.35.e87. Online ahead of print. J Gynecol Oncol. 2024. PMID: 38606827 Free article. No abstract available.
QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.
Fang C, Zhou Y, Feng Y, He L, Yu J, Li Y, Feng M, Pan M, Zhao L, Tang D, Li X, Tan B, An R, Zheng X, Si M, Zhang B, Li L, Kang X, Zhou Q, Liu J. Fang C, et al. Among authors: liu j. J Gynecol Oncol. 2024 Mar 29. doi: 10.3802/jgo.2024.35.e77. Online ahead of print. J Gynecol Oncol. 2024. PMID: 38606822 Free article.
877 results